SteelPeak Wealth’s Sanofi SNY Stock Holding History

SteelPeak Wealth’s Portfolio SNY Stock Details SNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-6,851	Closed	-$260K	–	471
2022 Q3	$260K	Hold	6,851	–	–	0.02%	338
2022 Q2	$343K	Buy	+6,851	New	+$364K	0.02%	301

Other funds holding SNY

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

SteelPeak Wealth's SNY Position: Q4 2022 in Review

SteelPeak Wealth sold out of Sanofi (SNY) in Q4 2022, closing a stake of 6,851 shares — an estimated $260K sold.

SteelPeak Wealth first reported a position in SNY in Q2 2022 and held it in 2 quarters. The position peaked at $343K in Q2 2022. 643 funds tracked by Wall St. Rank hold SNY as of Q4 2022.

SteelPeak Wealth reported no remaining Sanofi position as of Q4 2022 after selling out during the quarter.
SteelPeak Wealth sold 6,851 Sanofi shares in Q4 2022, an estimated $260K.
SteelPeak Wealth first reported a position in Sanofi in Q2 2022 and held it in 2 quarters.
SteelPeak Wealth's Sanofi position peaked at $343K in Q2 2022.
643 funds tracked by Wall St. Rank held Sanofi as of Q4 2022.

Based on SteelPeak Wealth's 13F filing for Q4 2022, filed 25 Jan 2023.